戻る
「早戻しボタン」を押すと検索画面に戻ります。

今後説明を表示しない

[OK]

コーパス検索結果 (1語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1      These ferrets did not shed the virus or seroconvert.
2 al challenges with SIV(mac251) and failed to seroconvert.
3 ers in sera than those whose infants did not seroconvert.
4  project who were exposed to HIV but did not seroconvert.
5 ate (CA2), even though these animals did not seroconvert.
6 on of HPV-16 DNA than were women who did not seroconvert.
7 e immunity, but not all infected individuals seroconvert.
8  tissue inflammatory response, and failed to seroconvert.
9  in serum and IC were generally low, and 65% seroconverted.
10 r H+ pigs (66%) than non-A+ or H+ pigs (25%) seroconverted.
11                     Overall, 64% of patients seroconverted.
12  oronasally and i.v. inoculated chickens had seroconverted.
13 l exposure group shed the virus in feces and seroconverted.
14  immunization and for 52 weeks for those who seroconverted.
15 of 15 initially negative children, 5 (33.3%) seroconverted.
16 e from Europe, Australia, and Canada who had seroconverted.
17 ronegative for measles; of these, 44 (93.6%) seroconverted.
18 t exhibited mild clinical symptoms, but they seroconverted.
19 er, some women with persistent HPV DNA never seroconverted.
20 osures and remained asymptomatic, and no one seroconverted.
21 patients with HBV DNA levels >104 genomes/mL seroconverted.
22 ter 2 injections, all subjects in all groups seroconverted.
23 ds, and 50 to 60% of 3-, 4-, and 5-year-olds seroconverted.
24 ll horses at various time points; two horses seroconverted.
25 s and Swiss Webster mice inoculated with CA9 seroconverted.
26            For chimera 3, none of 9 subjects seroconverted.
27 5 (20%) of 25 initially seronegative persons seroconverted.
28  and 67.1% of women with incident infections seroconverted.
29 lthough the virus replicated and the animals seroconverted.
30                        235 (12%) individuals seroconverted.
31 and CD86 on B cells was high in patients who seroconverted.
32 en if either they or their male partners HIV seroconverted.
33 d more than one follow-up test and 238 (17%) seroconverted.
34 nd three of 41 placebo recipients (7%, 2-20) seroconverted.
35 inical efficacy equivalent to the proportion seroconverting.
36                    One transfusion recipient seroconverted (0.08% [1/1259]), but this patient did not
37 tients who did not receive transfusions also seroconverted (0.18% [1/556]).
38          Of 253 HIV-negative participants, 2 seroconverted (0.29/100 person-years at risk [pyar]); of
39  20 of 193 (10%) infants in the latter group seroconverted 1 week after mOPV2 challenge, resulting in
40                    For chimera 4, 7 subjects seroconverted (1 received 10 PFU, 3 received 100 PFU, an
41                    For chimera 2, 3 subjects seroconverted (1 received 100 PFU, and 2 received 1000 P
42                             Thirty-six (15%) seroconverted (10%-12%/year).
43             Most ANDV-infected deer mice had seroconverted 14 days after inoculation, but none of the
44 dition, 80% (8/10; phase II) of infected RMs seroconverted 14 to 21 days postchallenge.
45 -years in the control group 158 participants seroconverted (31.78 per 100 person-years; 26.83-36.74).
46           One full dose of intramuscular IPV seroconverted 33%, 41%, and 47% of infants against serot
47 less of OPV formulation, were less likely to seroconvert (47%; 95% confidence interval, 39%-54%) than
48  patients with Kaposi's sarcoma (52 percent) seroconverted 6 to 75 months before the clinical appeara
49 1, 2, and 3 on average, whereas 2 full doses seroconverted 79%, 80%, and 90%, respectively.
50 rted than among those whose partners did not seroconvert (90,254 copies per milliliter vs. 38,029 cop
51 t year were 5.1 times as likely as others to seroconvert (95% CI 1.9-13.7).
52 had sex with men were 8.8 times as likely to seroconvert (95% CI 3.7-20.5) as heterosexual men.
53 histolytica infections, as 15.3% of controls seroconverted after 12 months of follow-up.
54 es at 0, 4, and 12-15-months, and almost all seroconverted after 2 doses given 8-11 months apart.
55 s who were HAV seronegative at baseline, 97% seroconverted after 2 vaccine doses, and 47% had low ant
56  cytomegalovirus (CMV); 6 (5 female, 1 male) seroconverted after a median of 7.5 months.
57  higher percentage of healthy subjects (93%) seroconverted after a single dose of the hepatitis A vac
58 noculated with tetravalent YF/DEN1-4 vaccine seroconverted after a single dose.
59                                Mice that had seroconverted after exposure to P. carinii-infected SCID
60 bsequent dried blood spot tests, of whom 503 seroconverted after follow-up of 22 891 person-years.
61 ho were type-2 seronegative, 42 (100%) of 42 seroconverted after GlaxoSmithKline intramuscular IPV, a
62                                  The patient seroconverted after immune reconstitution during receipt
63 ) of 97 infants who were type-3 seronegative seroconverted after intramuscular IPV, and 21 (36%) of 4
64 rt, we identified one individual (LSC63) who seroconverted after over 2 years of repeated unprotected
65 of the children seronegative at age 9 months seroconverted after receiving two doses of measles vacci
66                   However, 18 of 19 children seroconverted after revaccination.
67        Similarly, mothers whose infants' IgA seroconverted after RV1 had significantly lower pre-dose
68 nza-like symptoms and lung lesions, and they seroconverted after virus inoculation.
69                             All participants seroconverted against all 4 serotypes after receiving 3
70 5,5,5,5) or a low-dose (3,3,3,3) formulation seroconverted against all four DEN virus serotypes.
71  of 117, or 99%) of these young patients had seroconverted against Epstein-Barr virus, as compared wi
72 h higher diarrhea scores were more likely to seroconvert and developed higher intestinal IgA and IgG
73 ing 30% of the transplant recipients did not seroconvert and were asymptomatic.
74  who were HIV-negative, 536 were observed to seroconvert and were followed up for up to 13 years.
75 -FIV activity during acute infection did not seroconvert and yielded no evidence of FIV infection at
76          The percentages of participants who seroconverted and achieved seroprotection were similar b
77                  All vaccinated animals were seroconverted and developed neutralizing antibody respon
78 ss I loci was performed for 850 patients who seroconverted and had known dates of HIV-1 infection.
79 ct control pigs shed the virus in feces; two seroconverted and one became viremic.
80   Comparisons were made between children who seroconverted and progressed to type 1 diabetes (progres
81 ted; of the 15 whose serostatus changed, all seroconverted and were significantly younger than those
82 riments did not show clinical signs, did not seroconvert, and did not have detectable M. agassizii by
83            Uninoculated cage mates failed to seroconvert, and viral RNA was not detected in their tis
84  percent of the HuNoV-HS66-inoculated calves seroconverted, and 100% coproconverted with immunoglobul
85 men had acute HIV infection at enrollment, 4 seroconverted, and 2 were identified as recently infecte
86    Of 148 healthy child vaccinees, 113 (76%) seroconverted, and 24% had no detectable VZV FAMA antibo
87 All of the experimentally infected tortoises seroconverted, and levels of antibody were statistically
88  cattle in both treatment and contact groups seroconverted, and virus was detected in their respirato
89  These effects counterbalance, and women who seroconverted at 24-30 weeks of gestation carried the hi
90                       The inoculated turkeys seroconverted at 4 to 8 wpi.
91 ens inoculated with the 10(-2) dilution also seroconverted at 8 wpi.
92  [5-21] at 10 years among those patients who seroconverted at ages < 15, 15-34, 35-54, and > or = 55)
93                                 Both animals seroconverted at least 6 months after the interruption o
94 y-infused animal until week 12; both animals seroconverted at week 14.
95 le genes of the gtrA,B, gtr(type) cluster in seroconverting bacteriophages.
96 f the AIDS-KS patients who were examined IgG-seroconverted before KS development, and antibody levels
97                            An additional 22% seroconverted before or after transplant, and were asymp
98  group and 157 of 1 184 in the placebo group seroconverted between months 13 and 25, giving a vaccine
99 e-control study comparing 58 respondents who seroconverted between visits with 1134 controls who rema
100 eived EBV+ grafts; 8 others with EBV+ grafts seroconverted but did not become symptomatic.
101 ificantly lower than in men who subsequently seroconverted but had no evidence of early infection.
102 ccines) developed subclinical infections and seroconverted but were only partially protected against
103 d PCR amplification, whereas several rabbits seroconverted but were PCR and culture negative.
104                   H. hepaticus-infected mice seroconverted by 2 weeks and maintained ELISA reactivity
105 and groups 3 and 4 became virus positive and seroconverted by 3 to 5 weeks postinoculation.
106                        Of these, 676 (98.8%) seroconverted by age 16 months.
107  On the basis of an aoHGE lysate ELISA, mice seroconverted by day 10 after inoculation.
108 tibody reactivity, and only six case mothers seroconverted by either assay.
109 s: one, four, four, and one person of eleven seroconverted by haemagglutination inhibition, microneut
110 We found that 13 of 22 D(+)R(-) LTRs (59.1%) seroconverted (CMV IgG Ab(+)).
111 he booster dose, 98% of compensated patients seroconverted compared with 65.7% with decompensated dis
112                         The group of 536 who seroconverted constituted the study population.
113 Twenty of these specimens were from recently seroconverted drug-naive persons, and 30 were from patie
114 first pandemic wave, 12.2% of the population seroconverted due to infection and the seroprevalence af
115 and the proportion of those susceptible that seroconverted due to infection, from a single sample of
116 icate that 30% of children and 33% of adults seroconvert during interferon-alpha treatment and follow
117 we attempted to classify TDR among women who seroconverted during 2008-2010 and who were identified f
118   Four of 17 initially seronegative partners seroconverted during 23 person-years of observation.
119 ined asymptomatic, and none of these animals seroconverted during an extended quarantine period.
120 y, 3371 were HIV positive on entry, and 2737 seroconverted during follow-up (1962 had a seroconversio
121 413 initially HIV-uninfected participants, 8 seroconverted during follow-up.
122  on the transmission bottleneck in women who seroconverted during the CAPRISA 004 microbicide trial.
123                               Eight children seroconverted during the outbreak without revaccination
124                                The women who seroconverted during the trial reported a significant in
125 0) of the 28 controls with follow-up samples seroconverted (exact p value = 0.0008).
126 ent HPV DNA was associated with a failure to seroconvert following incident HPV infection; however, s
127                 Patients were more likely to seroconvert for a cross-reactive antigen if they serocon
128 valent or serotype G1-G4 tetravalent vaccine seroconverted for at least one of the six antibodies (85
129 erson-years of follow-up [PYFU], 16 patients seroconverted for HDV, with an overall incidence rate of
130 ected every 2-7 days from 15 individuals who seroconverted for HIV-1 infection in 1994-2000.
131 dent HPV infections, 59.5%, 54.1%, and 68.8% seroconverted for HPV-16, -18, or -6, respectively, with
132 convert for a cross-reactive antigen if they seroconverted for the specific vaccine antigen.
133 tive sex partners of HTLV-I and -II carriers seroconverted, for an incidence rate (IR) of 0.6 transmi
134  hepatitis B e antigen-positive patients who seroconverted from hepatitis B e antigen to hepatitis B
135                           15 875 individuals seroconverting from 1979 to 2008 fulfilled the inclusion
136  children, 73% older children and 72% adults seroconverted (&gt;/=4 fold titer rise) after the 1(st) OCV
137                  Interestingly, patients who seroconverted had significantly lower serum levels of G-
138  of mice with soluble protein (sTat), and in seroconverting humans, and propose that Tat-induced supp
139 h sera obtained from four pregnant women who seroconverted (IgG and IgM antibodies) during pregnancy
140               Dogs have been demonstrated to seroconvert in response to diverse IAVs, and naturally o
141 ll product were significantly more likely to seroconvert in response to the influenza vaccine (P = .0
142      After MMR3, 82% (14/17) and 91% (10/11) seroconverted in 7-10 days and 2-3 months, respectively.
143  homologous to the outbreak strain, but most seroconverted in response to other genetically distinct
144 nfection in disease progression in women who seroconverted in the CAPRISA 004 tenofovir microbicide t
145 of the 415 initially HIV-1-negative partners seroconverted (incidence, 11.8 per 100 person-years).
146 0 person-years of follow-up, 29 participants seroconverted (incidence: 10.0/100 person-years).
147 +)IFN-gamma(+) T cells in the PBMC of 90% of seroconverted individuals following primary infection by
148 -negative OFOQ results occurred in 80 of 287 seroconverting individuals.
149 milar sequences were also determined from 18 seroconverting injection drug users in Baltimore.
150 ion of HIV-1 env sequences was studied in 15 seroconverting injection drug users selected for differe
151 eripheral blood mononuclear cells of the EBV-seroconverted kidney recipient 20 months after lymphoma
152 y day 57, 52 (92%) of vaccine recipients had seroconverted (microneutralisation titre >/=1:10), with
153  titres, the percentage of participants that seroconverted, microneutralisation titres, and the numbe
154                    The number of infants who seroconverted or had a four-fold rise in titres was also
155 who had >/=1 additional HCV Ab test, 23 (6%) seroconverted over 1408 person-years, for an annualized
156  respiratory disease than those that did not seroconvert (P < 0.001), and dogs with preexisting antib
157 cell losses (P < or = 0.013), and failure to seroconvert (P < or = 0.005) were correlated statistical
158 evels significantly higher than in the never-seroconverted (P = 0.02) and the pre-seroconverted (P =
159 e never-seroconverted (P = 0.02) and the pre-seroconverted (P = 0.03) children, but then declined to
160 iable models, early set-point viral loads in seroconverting partners were a complex function of (i) t
161 all pairs near the time of transmission, and seroconverting partners were followed for a median of 84
162                                        Of 64 seroconverted patients followed for at least 30 months o
163                        Eighty-two of the 142 seroconverted patients have stopped producing antibody t
164                                        Among seroconverted patients, after 30-36 mo of treatment, sev
165  high proportion of SRA positivity among EIA-seroconverting patients (8/11 [73%]) suggests that patie
166 ng the gp120 proteins of isolates from early seroconverting patients.
167                    The majority (75%) of the seroconverted population had no detectable levels of cir
168      Thirteen infected dogs (group A), which seroconverted rapidly (maximum titers within 50 to 90 da
169 R(+) CD8(+) T cells was greater in those who seroconverted, relative to the frequency in those who re
170 in addition to bOPV, 80% and 100% of infants seroconverted, respectively, and the vaccination induced
171  101 (3%), 41 (33%), and 25 (1%) of patients seroconverted, respectively.
172  receptive anal intercourse without a condom seroconverted significantly more often than those report
173 gh sex between men, aged 30-39 years, having seroconverted since 2006, enrolled within 6 months of se
174 ogs with mild or no clinical signs (group B) seroconverted slowly (peak titers after 90 days), and on
175                                   Few of the seroconverting subjects reported hepatitis-like illness.
176 rtner who injected drugs were less likely to seroconvert than other women (0.32 [0.11-0.92]).
177 l (to <104 genomes/mL) appear more likely to seroconvert than patients who do not achieve this level
178 en younger than 40 years were more likely to seroconvert than those 40 years or older (2.8 [1.05-7.6]
179 among HIV-1-positive subjects whose partners seroconverted than among those whose partners did not se
180                        For chimera 1, 1 of 9 seroconverted (the seroconverter received 100 PFU).
181       Moreover, treatment responders did not seroconvert to islet cell antibodies.
182 ernatants from the same cell line, failed to seroconvert to VCA and did not develop disease.
183 e, 47 (62%) of 76 participants given vaccine seroconverted to all four serotypes and 73 (96%) partici
184 h1 cytokines in patients who cleared HBV and seroconverted to anti- hepatitis B e, unlike the 23 nonr
185                                         Five seroconverted to anti-HBs (responders).
186 he Transfusion-Transmitted Viruses Study who seroconverted to anti-HCV after receiving infected blood
187                      All HEV-inoculated pigs seroconverted to anti-HEV immunoglobulin G.
188 he virus in feces; two pigs were viremic and seroconverted to anti-HEV.
189                However, fewer than one-third seroconverted to any prototype G1-G4 human rotavirus.
190                          Five of ten animals seroconverted to C. trachomatis.
191 t by day 62 postvaccination, 100% of animals seroconverted to DENV-1, -2, -3, and -4.
192 icipants, 39% (420/1077) and 53% (1595/2997) seroconverted to DENV-3 and DENV-4, respectively.
193 L/129 IL-10(-/-) mice were colonized and had seroconverted to H. saguini antigen with a significant T
194 ependent regression analyses: 48 of 195 IDUs seroconverted to HCV, for an incidence rate of 25.1/100
195  mean follow-up time, 39 months), 69 (33.2%) seroconverted to HCV.
196  (elevated liver enzyme levels in serum) and seroconverted to HEV, those receiving an inoculum incuba
197 in 10 persons with chronic HCV infection who seroconverted to HIV and, over the next 3 years, had slo
198                         Overall, 277 persons seroconverted to HIV during 8,826.45 person-years of fol
199  case-control study of 116 case subjects who seroconverted to HIV during follow-up and 342 control su
200  to HIV-1 were compared with 184 men who had seroconverted to HIV positive and had lower risk.
201 tions (23.6/100 person-years), and 265 women seroconverted to HIV-1 (7.7/100 person-years).
202                            A total of 85 men seroconverted to HIV-1 over the period of observation, g
203                                     45 women seroconverted to HIV.
204  after the third QHPV dose, 67% of vaccinees seroconverted to HPV31, an HPV16-related genotype not in
205                  A total of 131 participants seroconverted to HSV-2 (79 of 1041 assigned to tenofovir
206 children vaccinated at 15 months of age, 98% seroconverted to measles, compared with 95% of those vac
207 with GAS pharyngitis and invasive infections seroconverted to most of the 16 recombinant proteins, wh
208    In the first outbreak, only three of nine seroconverted to NV, which was likely due to late collec
209 f the 106 eligible pairs tested, 21 patients seroconverted to one or more antigens.
210                                 Most animals seroconverted to only a subset of these fimbrial antigen
211                       Group 2 and 5 pigs all seroconverted to PCV1 antibody.
212 tvaccination (DPV), the majority of pigs had seroconverted to PCV2 capsid antibody.
213                           Inoculated rabbits seroconverted to positivity for antibodies against HTLV-
214 canis, and 25 to Bartonella vinsonii, and 22 seroconverted to Rickettsia rickettsii antigens.
215                   Five of the six volunteers seroconverted to S. enterica serovar Typhimurium antigen
216              Three of six (three of five who seroconverted to Salmonella) had immune responses in the
217         In the azithromycin group, 175 (50%) seroconverted to serotype-3 poliovirus compared with 192
218 al signs and symptoms of GAS pharyngitis and seroconverted to several GAS extracellular proteins.
219 ive infections and pharyngitis caused by GAS seroconverted to Shp, indicating that Shp was produced i
220  and patients with streptococcal pharyngitis seroconverted to Sse, indicating that Sse was produced i
221     Each monkey immunized with TV-1 and TV-3 seroconverted to the four DEN components by day 28 with
222 , and 16% of initially seronegative subjects seroconverted to the H3N2, B, and H1N1 antigens, respect
223 iitis) caused by six distinct M types of GAS seroconverted to the streptococcal cysteine protease.
224 dual patients demonstrated that the majority seroconverted to these proteins, confirming results with
225 all four serotypes and 73 (96%) participants seroconverted to three or more dengue viruses.
226 ants (100%, 98.0-100; p<0.0001 vs bOPV-only) seroconverted to type 2.
227 apsid antigen (VCA) of EBV; all animals that seroconverted to VCA developed malignant lymphoma within
228           For assay development: 104 persons seroconverting to HIV-1 comprising 38 plasma donors, 18
229                  The proportions of children seroconverting to type 2 poliovirus in the IPV-bOPV-bOPV
230 h Procleix HCV reactive/seronegative results seroconverted upon follow-up and were confirmed as Procl
231                                    Women who seroconverted were 5.7 times (95% confidence interval =
232 iduals enrolled in the iPrEx trial who later seroconverted were matched with 480 samples from enrolle
233 ir resistance remains a concern in women who seroconvert while using the gel despite the lack of plas
234     Dogs that were seronegative on entry but seroconverted while in the kennel were 4 times more like
235        Only 9% of subjects who received LAIV seroconverted, while 33% of patients developed at least
236 shed virus nasally or rectally, but all pigs seroconverted with antibodies to HRV.
237 rrhea and fecal and nasal virus shedding and seroconverted with serum and intestinal HRV antibodies.
238 unodeficiency virus type 1 (HIV-1) typically seroconvert within weeks of primary infection.
239 CR positive within 3 weeks postinfection and seroconverted without exhibiting clinical disease; howev
240         In contrast, almost all of those who seroconverted without illness (97%) experienced primary
241                                        Among seroconverting Zambian (n = 240) and Rwandan (n = 64) pa

WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。
 
Page Top